The state of Maryland is home to more than 500 core bioscience companies, representing the second largest per capital cluster in the U.S. These companies are involved in biotherapeutics, research services, diagnostics, medical devices, and more. So what exactly do these companies do and how do they differ from one another? Two renowned industry experts will explain the terminology and help you understand the types of work these companies are involved in. They will also discuss where the opportunities are for service providers, and how best to connect with the right people at the right time.

Speakers:

Timothy Fawcet,Ph.D.
Scientific Director, BioTechnical Institute (BTI) of Maryland
Scientific Director, BioSciConcepts

Paul Silber
Founder, President and CEO
Founding Member, Blu Venture Investors

Fee:

Premier Member: $0
Member Plus: $30
Non Member: $40

Register